Effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
agents	NNS	agent NNS PennPOS
on	IN	on IN PennPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
,	,	, , NUPOS
CTGF	NN	Ctgf NN PennPOS
and	CC	and cc NUPOS
IFN-gamma	NN	IFN-gamma NN PennPOS
expression	NN	expression NN PennPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
deadly	JJ	deadly JJ PennPOS
disease	NN	disease NN PennPOS
,	,	, , NUPOS
largely	RB	large av-j NUPOS
unresponsive	JJ	unresponsive JJ PennPOS
to	TO	to p-acp NUPOS
treatment	NN	treatment NN PennPOS
with	IN	with pp NUPOS
corticosteroids	NNS	corticosteroid NNS PennPOS
and	CC	and cc NUPOS
immunosuppressives	NNS	immunosuppressive NNS PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
aim	NN	aim NN PennPOS
of	IN	of pp-f NUPOS
this	DT	this d NUPOS
randomized	VBN	randomize VBN PennPOS
,	,	, , NUPOS
prospective	JJ	prospective JJ PennPOS
,	,	, , NUPOS
open-label	JJ	open-label JJ PennPOS
study	NN	study NN PennPOS
was	VBD	be vbd NUPOS
to	TO	to p-acp NUPOS
characterize	VB	characterize VBP PennPOS
the	DT	the dt NUPOS
molecular	JJ	molecular JJ PennPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
IFN-gamma-1b	NN	IFN-gamma-1b NN PennPOS
and	CC	and cc NUPOS
colchicine	NN	colchicine NN PennPOS
,	,	, , NUPOS
on	IN	on IN PennPOS
biomarkers	NNS	biomarker NNS PennPOS
expression	NN	expression NN PennPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
TGF-beta	NN	TGF-beta NN PennPOS
,	,	, , NUPOS
CTGF	NN	Ctgf NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
immunomodulatory/antimicrobial	JJ	immunomodulatory/antimicrobial JJ PennPOS
activity	NN	activity NN PennPOS
(	(	( ( NUPOS
IFN-gamma	NN	IFN-gamma NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lungs	NNS	lung NNS PennPOS
of	IN	of pp-f NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

Fourteen	CD	fourteen crd NUPOS
(	(	( ( NUPOS
14	CD	14 crd NUPOS
)	)	) ) NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
an	DT	a dt NUPOS
established	JJ	established JJ PennPOS
diagnosis	NN	diagnosis NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
received	VBD	receive VBD PennPOS
either	CC	either CC PennPOS
200	CD	200 crd NUPOS
microg	NN	microg NN PennPOS
of	IN	of pp-f NUPOS
IFN-gamma-1b	NN	IFN-gamma-1b NN PennPOS
subcutaneously	RB	subcutaneous RB PennPOS
three	CD	three crd NUPOS
times	NNS	time NNS PennPOS
per	IN	per IN PennPOS
week	NN	week NN PennPOS
,	,	, , NUPOS
or	CC	or cc NUPOS
1	CD	1 crd NUPOS
mg	NN	mg NN PennPOS
of	IN	of pp-f NUPOS
oral	JJ	oral JJ PennPOS
colchicine	NN	colchicine NN PennPOS
per	IN	per IN PennPOS
day	NN	day NN PennPOS
,	,	, , NUPOS
for	IN	for c-acp NUPOS
24	CD	24 crd NUPOS
months	NNS	month NNS PennPOS
.	.	. . NUPOS

Using	VBG	use VBG PennPOS
RT-PCR	NN	rt-pcr NN PennPOS
assay	NN	assay NN PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
evaluated	VBD	evaluate VBD PennPOS
the	DT	the dt NUPOS
transcription	NN	transcription NN PennPOS
levels	NNS	level NNS PennPOS
of	IN	of pp-f NUPOS
transforming-growth-factor-beta1	NN	transforming-growth-factor-beta1 NN PennPOS
(	(	( ( NUPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
connective-tissue	JJ	connective-tissue JJ PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
CTGF	NN	Ctgf NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
interferon-gamma	NN	interferon-gamma NN PennPOS
(	(	( ( NUPOS
IFN-gamma	NN	IFN-gamma NN PennPOS
)	)	) ) NUPOS
genes	NNS	gene NNS PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
tissue	NN	tissue NN PennPOS
before	IN	before c-acp NUPOS
and	CC	and cc NUPOS
after	IN	after c-acp NUPOS
treatment	NN	treatment NN PennPOS
with	IN	with pp NUPOS
IFN-gamma-1b	NN	IFN-gamma-1b NN PennPOS
or	CC	or cc NUPOS
colchicine	NN	colchicine NN PennPOS
.	.	. . NUPOS

Marked	JJ	marked JJ PennPOS
mRNA	NN	mRNA NN PennPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
and	CC	and cc NUPOS
CTGF	NN	Ctgf NN PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
complete	JJ	complete JJ PennPOS
lack	NN	lack NN PennPOS
of	IN	of pp-f NUPOS
interferon-gamma	NN	interferon-gamma NN PennPOS
was	VBD	be vbd NUPOS
detected	VBN	detect VBN PennPOS
in	IN	in IN PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
lung	NN	lung NN PennPOS
tissue	NN	tissue NN PennPOS
at	IN	at pp NUPOS
entry	NN	entry NN PennPOS
.	.	. . NUPOS

After	IN	after c-acp NUPOS
treatment	NN	treatment NN PennPOS
,	,	, , NUPOS
both	DT	both d NUPOS
groups	NNS	group NNS PennPOS
exhibited	VBD	exhibit VBD PennPOS
increased	VBN	increase VBN PennPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
IFN-gamma	NN	IFN-gamma NN PennPOS
gene	NN	gene NN PennPOS
at	IN	at pp NUPOS
6	CD	6 crd NUPOS
months	NNS	month NNS PennPOS
that	WDT	that WDT PennPOS
was	VBD	be vbd NUPOS
sustained	VBN	sustain VBN PennPOS
at	IN	at pp NUPOS
24	CD	24 crd NUPOS
months	NNS	month NNS PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
CTGF	NN	Ctgf NN PennPOS
and	CC	and cc NUPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
remained	VBD	remain VBD PennPOS
almost	RB	almost av NUPOS
stable	JJ	stable JJ PennPOS
before	IN	before c-acp NUPOS
and	CC	and cc NUPOS
after	IN	after c-acp NUPOS
treatment	NN	treatment NN PennPOS
,	,	, , NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
IFN-gamma-1b	JJ	ifn-gamma-1b JJ PennPOS
group	NN	group NN PennPOS
,	,	, , NUPOS
while	IN	while cs NUPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
was	VBD	be vbd NUPOS
statistically	RB	statistical av-j NUPOS
decreased	VBN	decrease VBN PennPOS
after	IN	after c-acp NUPOS
therapy	NN	therapy NN PennPOS
,	,	, , NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
colchicine	NN	colchicine NN PennPOS
group	NN	group NN PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.0002	CD	0.0002 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Significant	JJ	significant JJ PennPOS
difference	NN	difference NN PennPOS
in	IN	in IN PennPOS
DLCO	NNP	DLCO NNP PennPOS
(	(	( ( NUPOS
%	NN	% NN PennPOS
pred	VBN	pr VBN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
was	VBD	be vbd NUPOS
found	VBN	find VBN PennPOS
between	IN	between IN PennPOS
the	DT	the dt NUPOS
two	CD	two crd NUPOS
treatment	NN	treatment NN PennPOS
groups	NNS	group NNS PennPOS
in	IN	in IN PennPOS
favor	NN	favor NN PennPOS
of	IN	of pp-f NUPOS
IFN-gamma-1b	NN	IFN-gamma-1b NN PennPOS
group	NN	group NN PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.04	CD	0.04 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
addition	NN	addition NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
IFN-gamma-1b	JJ	ifn-gamma-1b JJ PennPOS
group	NN	group NN PennPOS
showed	VBD	show VBN PennPOS
stability	NN	stability NN PennPOS
in	IN	in IN PennPOS
arterial	JJ	arterial JJ PennPOS
PO2	NN	PO2 NN PennPOS
while	IN	while cs NUPOS
the	DT	the dt NUPOS
colchicine	NN	colchicine NN PennPOS
group	NN	group NN PennPOS
significantly	RB	significant av-j NUPOS
deteriorated	JJ	deteriorated JJ PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.02	CD	0.02 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
conclusion	NN	conclusion NN PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
report	VBP	report VBP PennPOS
the	DT	the dt NUPOS
effect	NN	effect NN PennPOS
of	IN	of pp-f NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
agents	NNS	agent NNS PennPOS
(	(	( ( NUPOS
IFN-gamma-1b	NN	IFN-gamma-1b NN PennPOS
and	CC	and cc NUPOS
colchicine	NN	colchicine NN PennPOS
)	)	) ) NUPOS
in	IN	in IN PennPOS
TGF-beta	NN	TGF-beta NN PennPOS
,	,	, , NUPOS
CTGF	NN	Ctgf NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
endogenous	JJ	endogenous JJ PennPOS
IFN-gamma	NN	IFN-gamma NN PennPOS
gene	NN	gene NN PennPOS
expression	NN	expression NN PennPOS
,	,	, , NUPOS
in	IN	in IN PennPOS
human	JJ	human JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

However	RB	however a-acp NUPOS
,	,	, , NUPOS
extended	JJ	extended JJ PennPOS
studies	NNS	study NNS PennPOS
are	VBP	be vbb NUPOS
needed	VBN	need VBN PennPOS
to	TO	to p-acp NUPOS
verify	VB	verify VBP PennPOS
the	DT	the dt NUPOS
pathophysiological	JJ	pathophysiological JJ PennPOS
consequences	NNS	consequence NNS PennPOS
of	IN	of pp-f NUPOS
these	DT	these d NUPOS
findings	NNS	finding n2 NUPOS
.	.	. . NUPOS

